SUPPORT FOR THE ROSE F KENNEDY IDDRC P50
支持 ROSE F KENNEDY IDDRC P50
基本信息
- 批准号:10239747
- 负责人:
- 金额:$ 100万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-23 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:22q11AdvocateAffectAnimal BehaviorAnimalsBasic ScienceBiologicalBiologyChargeChildClinicClinicalClinical ResearchClinical TrialsCollaborationsCommunitiesCommunity OutreachCoupledDiagnosisDiseaseDisorder of neurometabolic regulationEarly DiagnosisEducational workshopEpigenetic ProcessEvaluationFacultyFaculty RecruitmentFamilyFosteringFundingGangliaGenesGenetic TranscriptionGenomicsGoalsGrantHeadHospitalsHumanHuman ResourcesImageInfantInfantile spasmsInstitutionIntellectual and Developmental Disabilities Research CentersIntellectual functioning disabilityLaboratory ResearchLeadershipLinkLysineMedicalMedical centerMedicineMetabolismMissionMonitorMutationNational Institute of Child Health and Human DevelopmentNeonatal ScreeningNeurodevelopmental DisorderNeurofibromatosesNeuronsNewsletterOnline SystemsOutcomeParticipantPathogenesisPathway interactionsPatient CarePatientsPediatric HospitalsPhenotypePostdoctoral FellowQuality ControlRecruitment ActivityRehabilitation CentersResearchResearch PersonnelResearch Project GrantsRett SyndromeRoleScienceScientistServicesSolidStructureStudentsTNFRSF5 geneTalentsTechnologyTimeTrainingTraining ProgramsTranslatingTranslational ResearchTuberous SclerosisUniversitiesUrsidae FamilyVisualizationWilliams Syndromeanimal tissuearmautism spectrum disorderbrain cellcellular engineeringcellular imagingclinical careclinical phenotypecollegecost effectivenessdesigndevelopmental diseasehuman tissueimaging facilitiesimprovedinnovationinsightmembermultidisciplinarymultimodalityneurogenomicsnext generationnoveloperationoutreachoutreach programprecision medicinepreventprogramsresearch studyscreening programsymposiumtool
项目摘要
PROJECT SUMMARY/ABSTRACT (OVERALL)
The overarching purpose of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center
(RFK IDDRC) is to improve the lives of children with intellectual and developmental disabilities (IDDs). Fifty-
plus years of distinguished progress in basic, translational and clinical research as one of NICHD’s flagship
IDDRCs, coupled with important recent faculty recruitments and an historic merger between the Albert Einstein
College of Medicine and its University-Affiliated Hospital, Montefiore Medical Center, offer a solid platform for
continuing excellence in our commitment to IDD research. The Center’s 4 highly integrated scientific Cores
consist of: 1) our clinical translational core known as the Human Clinical Phenotyping (Core B, HCP), which
serves to facilitate both access to and characterization of participants for IDD relevant research; 2) a
Neurogenomics facility (Core C, NGEN) that provides cutting edge epigenetic and genomic processing and
analyses on both human and animal tissues; 3) a Neural Cell Engineering and Imaging facility (Core D,
NCEI) that provides state-of-the-art approaches to brain cell manipulation and visualization; and 4) an Animal
Phenotyping facility (Core E, AP) for evaluation of animal behavior, metabolism and imaging in a manner with
strong parallels to approaches taken in patients accessed through HCP. Each of our scientific Cores is
carefully overseen and monitored by the Administrative Core (Core A, ADM), which also serves as the head
ganglion of the entire IDDRC in its substantial outreach programs to Einstein/Montefiore, the Bronx community
as well as nationally. Each scientific Core has an essential connection to our signature Research Project
which brings together a multidisciplinary team of investigators focused on mechanisms of IDD in children with
mutations in the transcriptional regulator lysine demethylase 5c gene, KDM5C. A central function of the RFK
IDDRC is to promote the substantive links between Einstein research laboratories and clinics at the Children's
Evaluation and Rehabilitation Center (CERC) and the Children’s Hospital At Montefiore (CHAM). Together, our
Cores and research project form a dynamic network – a community – of IDD-focused programs and practices
that interlink 18 different academic departments, >100 IDDRC members and 20-plus IDD-relevant clinics at
Einstein and Montefiore. The latter include 22q11.2DS, Rett and Williams syndromes, tuberous sclerosis,
neurofibromatosis, West syndrome and infantile spasms, autism spectrum disorders, and a wide range of
neurometabolic disorders. New initiatives moving forward at this time include our unique precision
medicine/community outreach program we call Operation IDD Gene Team, our goal to fortify ties with our
Einstein clinical partner (CERC and its affiliated UCEDD and LEND programs) under the umbrella of the Rose
F. Kennedy Center and a heightened focus on training through our newly established T32 for IDD postdoctoral
fellows.
项目总结/摘要(总体)
玫瑰F的首要目的是。肯尼迪智力和发育障碍研究中心
(RFK IDDRC)是为了改善智力和发育残疾儿童的生活。五十-
加上多年来作为NICHD旗舰之一在基础、转化和临床研究方面取得的杰出进展
IDDRCs,加上最近重要的教师招聘和阿尔伯特爱因斯坦之间的历史性合并
医学院及其大学附属医院,蒙蒂菲奥里医疗中心,提供了坚实的平台,
继续致力于IDD研究。该中心的4个高度集成的科学核心
包括:1)我们的临床翻译核心,称为人类临床表型(核心B,HCP),
有助于接触缺碘症相关研究的参与者并确定其特征; 2)a
神经基因组学设施(核心C,NGEN),提供尖端的表观遗传和基因组处理,
对人和动物组织的分析; 3)神经细胞工程和成像设备(核心D,
NCEI),其提供最先进的脑细胞操作和可视化方法;以及4)动物
表型分析机构(Core E,AP),用于评价动物行为、代谢和成像,
与通过HCP访问的患者中采用的方法非常相似。我们的每一个科学核心
由行政核心(核心A,ADM)仔细监督和监测,行政核心也是负责人
整个IDDRC的神经节在其大量的推广计划,爱因斯坦/蒙蒂菲奥里,布朗克斯社区
以及全国范围内。每个科学核心都与我们的签名研究项目有着重要的联系
它汇集了一个多学科的调查小组,重点是儿童缺碘症的机制,
转录调节因子赖氨酸脱甲基酶5c基因KDM 5C突变。肯尼迪中心的一项核心职能是
IDDRC是为了促进爱因斯坦研究实验室和儿童医院诊所之间的实质性联系。
评估和康复中心(CERC)和蒙蒂菲奥里儿童医院(CHAM)。我们一起,
核心和研究项目形成了一个动态网络-一个社区-以缺碘症为重点的方案和做法
该中心将18个不同的学术部门、100多个IDDRC成员和20多个IDD相关诊所连接在一起,
爱因斯坦和蒙蒂菲奥里后者包括22q11.2DS,Rett和威廉姆斯综合征,结节性硬化症,
神经纤维瘤病,韦斯特综合征和婴儿痉挛症,自闭症谱系障碍,以及广泛的
神经代谢紊乱新的举措在这个时候向前迈进,包括我们独特的精度
医学/社区外展计划,我们称之为行动IDD基因团队,我们的目标是加强与我们的联系,
Einstein临床合作伙伴(CERC及其附属的UCEDD和LEND计划)在玫瑰的保护伞下
F.肯尼迪中心和通过我们新成立的T32 IDD博士后培训的高度重视
伙计们
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SOPHIE MOLHOLM其他文献
SOPHIE MOLHOLM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SOPHIE MOLHOLM', 18)}}的其他基金
SUPPORT FOR THE ROSE F KENNEDY IDDRC P50
支持 ROSE F KENNEDY IDDRC P50
- 批准号:
10669059 - 财政年份:2021
- 资助金额:
$ 100万 - 项目类别:
SUPPORT FOR THE ROSE F KENNEDY IDDRC P50
支持 ROSE F KENNEDY IDDRC P50
- 批准号:
10455674 - 财政年份:2021
- 资助金额:
$ 100万 - 项目类别:
Training in Intellectual and Developmental Disabilities (IDD) Research
智力和发育障碍 (IDD) 研究培训
- 批准号:
10636634 - 财政年份:2020
- 资助金额:
$ 100万 - 项目类别:
Training in Intellectual and Developmental Disabilities (IDD) Research
智力和发育障碍 (IDD) 研究培训
- 批准号:
10404641 - 财政年份:2020
- 资助金额:
$ 100万 - 项目类别:
Training in Intellectual and Developmental Disabilities (IDD) Research
智力和发育障碍 (IDD) 研究培训
- 批准号:
10206216 - 财政年份:2020
- 资助金额:
$ 100万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 100万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 100万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 100万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 100万 - 项目类别: